As of 2026-09-11, the Relative Valuation of Moderna Inc (MRNA) is (180.66) USD. This relative valuation is based on P/E multiples. With the latest stock price at 136.62 USD, the upside of Moderna Inc based on Relative Valuation is -232.2%.
The range of the Relative Valuation is (173.91) - (152.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 19.2x | 19.2x |
| Forward P/E multiples | 21.9x - 29.3x | 26.3x |
| Fair Price | (173.91) - (152.47) | (180.66) |
| Upside | -227.3% - -211.6% | -232.2% |
| Date | P/E |
| 2026-09-09 | -17.08 |
| 2026-09-08 | -17.67 |
| 2026-09-04 | -18.33 |
| 2026-09-03 | -18.75 |
| 2026-09-02 | -18.99 |
| 2026-09-01 | -19.43 |
| 2026-08-31 | -17.67 |
| 2026-08-28 | -17.38 |
| 2026-08-27 | -17.98 |
| 2026-08-26 | -18.85 |
| 2026-08-25 | -20.00 |
| 2026-08-24 | -17.49 |
| 2026-08-21 | -18.28 |
| 2026-08-20 | -16.79 |
| 2026-08-19 | -21.96 |
| 2026-08-18 | -7.93 |
| 2026-08-17 | -8.12 |
| 2026-08-14 | -7.97 |
| 2026-08-13 | -8.02 |
| 2026-08-12 | -8.02 |
| 2026-08-11 | -7.63 |
| 2026-08-10 | -7.53 |
| 2026-08-07 | -7.45 |
| 2026-08-06 | -6.78 |
| 2026-08-05 | -7.08 |
| 2026-08-04 | -7.18 |
| 2026-08-03 | -6.94 |
| 2026-07-31 | -6.90 |
| 2026-07-30 | -7.29 |
| 2026-07-29 | -6.86 |
| 2026-07-28 | -7.03 |
| 2026-07-27 | -7.01 |
| 2026-07-24 | -6.81 |
| 2026-07-23 | -7.18 |
| 2026-07-22 | -7.31 |
| 2026-07-21 | -7.51 |
| 2026-07-20 | -7.49 |
| 2026-07-17 | -7.78 |
| 2026-07-16 | -7.95 |
| 2026-07-15 | -8.60 |
| 2026-07-14 | -8.49 |
| 2026-07-13 | -8.44 |
| 2026-07-10 | -8.60 |
| 2026-07-09 | -9.64 |
| 2026-07-08 | -9.29 |
| 2026-07-07 | -10.05 |
| 2026-07-06 | -10.30 |
| 2026-07-02 | -10.04 |
| 2026-07-01 | -9.13 |
| 2026-06-30 | -8.82 |